Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceGut health

Espinheira Santa

Brazil's best-known gastric herb (Monteverdia/Maytenus ilicifolia) has one modern randomized trial showing it is non-inferior to omeprazole for reflux dyspepsia — but that trial had no placebo arm, and commercial product adulteration is well documented. Promising, not proven.

What the science says

  • Relieves GERD and dyspepsia symptoms Limited evidence

    An 86-patient double-blind, double-dummy trial randomized people with GERD symptoms to omeprazole 20 mg, M. ilicifolia 400 mg, or M. ilicifolia 860 mg for 4 weeks. All three arms significantly improved symptom and quality-of-life scores with no differences between them, and the authors concluded non-inferiority to omeprazole. The critical caveat is that there was no placebo arm, so a large regression-to-the-mean and placebo effect cannot be separated from a real drug effect — 'as good as omeprazole' is not the same as 'better than nothing.'

  • Heals or prevents gastric ulcers Limited evidence

    The antiulcer story rests on rodent work: the triterpenes friedelin and friedelan-3-beta-ol isolated from the leaves reduce ethanol- and indomethacin-induced gastric lesions in rats, and leaf extracts inhibit Helicobacter pylori in vitro. No human ulcer-healing trial with endoscopic endpoints exists.

  • You are probably not getting real espinheira santa Moderate evidence

    Authentication studies using morpho-anatomy, microscopy, and HPTLC repeatedly find commercial 'espinheira-santa' products substituted with look-alike species such as Sorocea bonplandii and Zollernia ilicifolia, which share the spiny leaf shape but not the chemistry. This is the single most practical problem with the category: buy only products standardized to leaf flavonoids or catechins.

Dosage & safety

Studied doseThe GERD trial used a standardized dry leaf extract at 400 mg or 860 mg per day, taken as three capsules before breakfast and three before dinner for 4 weeks — both doses performed identically, so the lower one is sufficient. Traditional and Brazilian pharmacopoeia preparation is an infusion of 1-2 g of dried leaves up to three times daily, taken before meals.
SafetyWell tolerated in the 4-week trial, with adherence around 76% and no notable adverse events. Traditional practice avoids it during breastfeeding because of reported reduction in milk production, and rat studies at supratherapeutic doses have examined effects on fertility and neurobehavior, so pregnancy and lactation are best avoided. Pharmacokinetic work using midazolam as a probe suggests possible CYP3A-mediated drug interactions — relevant if you take statins, benzodiazepines, or immunosuppressants. Espinheira santa is not a substitute for investigating alarm symptoms such as bleeding, weight loss, or dysphagia.

Scientific references

Where to buy

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Gut health